- Home
- GHG vs VNDA Comparison
GHG vs VNDA Comparison
Compare GHG & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHG
- VNDA
- Stock Information
- Founded
- GHG 2004
- VNDA 2002
- Country
- GHG China
- VNDA United States
- Employees
- GHG N/A
- VNDA N/A
- Industry
- GHG Hotels/Resorts
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- GHG Consumer Discretionary
- VNDA Health Care
- Exchange
- GHG Nasdaq
- VNDA Nasdaq
- Market Cap
- GHG 259.8M
- VNDA 270.0M
- IPO Year
- GHG 2018
- VNDA 2006
- Fundamental
- Price
- GHG $2.55
- VNDA $4.79
- Analyst Decision
- GHG
- VNDA Strong Buy
- Analyst Count
- GHG 0
- VNDA 2
- Target Price
- GHG N/A
- VNDA $15.50
- AVG Volume (30 Days)
- GHG 14.7K
- VNDA 687.2K
- Earning Date
- GHG 02-25-2025
- VNDA 02-05-2025
- Dividend Yield
- GHG 3.91%
- VNDA N/A
- EPS Growth
- GHG N/A
- VNDA N/A
- EPS
- GHG 0.28
- VNDA N/A
- Revenue
- GHG $201,166,731.00
- VNDA $190,858,000.00
- Revenue This Year
- GHG N/A
- VNDA $5.60
- Revenue Next Year
- GHG $8.78
- VNDA $42.85
- P/E Ratio
- GHG $9.21
- VNDA N/A
- Revenue Growth
- GHG N/A
- VNDA N/A
- 52 Week Low
- GHG $2.31
- VNDA $3.46
- 52 Week High
- GHG $3.69
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- GHG 46.30
- VNDA 49.78
- Support Level
- GHG $2.40
- VNDA $4.49
- Resistance Level
- GHG $2.57
- VNDA $4.90
- Average True Range (ATR)
- GHG 0.10
- VNDA 0.18
- MACD
- GHG 0.01
- VNDA 0.02
- Stochastic Oscillator
- GHG 50.72
- VNDA 75.56
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.